30 closest matches · ranked by relevance
Prostatic Hyperplasia
Primary: Number of Events of Acute Urinary Retention (AUR) or Benign Prostatic Hyperplasia (BPH)-Related Prostatic Surgery at the Indicated Time Periods. — 29; 27; 40; 14 events…
Benign Prostatic Hypertrophy
Primary: International Prostate Symptom Score (IPSS) — -6.2; -5.1; -5.7 Units on a scale — p=0.371
Prostatic Hyperplasia
Primary: Number of Participants by Treatment Cohort With and Without a Benign Prostatic Hypertrophy (BPH) Diagnosis — 122307; 9456; 3293; 3674 participants
Benign Prostatic Hyperplasia (BPH)
Primary: International Prostate Symptom Score (IPSS) — 21.5; 21.4; -6.5; -3.6 Units on a 0 to 35 scale
Benign Prostatic Hyperplasia
Primary: Measuring Change From Baseline in International Prostate Symptom Score (IPSS) at 12 Weeks — 21.2; 21.2; -6.3; -3.4 Units on a scale
Benign Prostatic Hyperplasia
Primary: Change in International Prostate Symptom Scale (IPSS) of Lower Urinary Tract Symptoms From Baseline to 3 Months (Total Score at 3 Months Minus Total Score at Baseline)…
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 12 Weeks, International Prostate Symptom Score (IPSS) — -5.6; -3.6 Units on a Scale — p=0.004
Benign Prostatic Hyperplasia
Primary: International Prostate Symptom Score — 11.31 units on a scale
Benign Prostatic Hyperplasia (BPH)
Primary: Change From Baseline in Total International Prostate Symptom Score (IPSS) at 12 Weeks — -4.2; -6.3; -5.7 units on a scale — p=0.001
BPH
Primary: Primary Outcome; International Prostate Symptom Score Changes Between 4 Groups Compared to Baseline After 12 mo Treatment — 13.0; 12.0; 10.6; 13.4 score — p=<0.05
Benign Prostatic Hyperplasia · Prostatic Hyperplasia
Primary: Percent Change From Baseline in the Prostate Volume at Month 6 — -17.00; -2.77 percent change in volume — p=<0.0001
Benign Prostatic Hyperplasia
Primary: Adverse Events — 431; 188; 29; 0 participants
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 12 Week Endpoint in International Prostate Symptom Score (IPSS): Primary Analysis — 17.08; 17.30; -2.25; -4.92 units on a scale — p=<0.001
Benign Prostatic Hyperplasia · Enlarged Prostate
Primary: Change in Total International Prostate Symptom Score (IPSS) From Baseline to 12 Weeks — -5.18; -3.76 units on a scale — p=0.001
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 12 Week Endpoint in Detrusor Pressure at Peak Urinary Flow Rate (PdetQmax) — 54.83; 56.87; 1.92; -2.95 centimeters of water (cm H20) — p=0.068
Benign Prostatic Hyperplasia
Primary: Change From Baseline in the Total International Prostate Symptom Score (IPSS) at Week 12 — 21.8; 21.5; -6.3; -5.6 Score on a scale
Prostatic Hyperplasia
Primary: Change From Baseline in International Prostate Symptom Score (IPSS) by Last Observation Carried Forward (LOCF) Approach at 24 Months — -4.07; -3.28; -3.73; -3.36 Score…
Benign Prostatic Hyperplasia
Primary: Number of Men With Treatment-emergent Dizziness — 9; 11 Participants — p=0.403
Benign Prostatic Hypertrophy
Primary: IPSS Change From Baseline — -5.6 Units on a scale — p=<0.001
BPH
Primary: Testosterone Area Below Baseline Interval — 21.0; 16.0; 54.6; 70.6 ng*days/mL
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 8-Week Endpoint in Arterial Resistive Index (RI) in the Prostate Transition Zone — -0.01; 0.00 ratio — p=0.121
Benign Prostatic Hyperplasia
Primary: International Prostate Symptom Score (IPSS) — 9.83; 13.6; -3.39; -5.94 units on a scale
Benign Prostatic Hyperplasia
Primary: Change From Baseline in International Prostate Symptom Score (IPSS) at Week 12 — 21.3; 20.2; 21.5; 20.7 Score on a scale
Benign Prostatic Hyperplasia
Primary: Percentage of Participants With Treatment Success — 84.9 percentage of participants
Benign Prostatic Hyperplasia · Lower Urinary Track Symptoms
Primary: American Urologic Association Symptom Score (AUASS) — 18.66; 14.16 score on a scale
Prostatic Hyperplasia · Benign Prostatic Hyperplasia · Adenoma, Prostatic
Primary: International Prostate Symptom Score (IPSS) Change From Baseline — -0.4; -5.0; -13.1; -12.6 score on a scale
Benign Prostatic Hyperplasia · Lower Urinary Tract Symptom
Primary: Efficacy: Change From Baseline in the International Prostate Symptom Score (IPSS) at 3 Month Follow-Up — -11.2; -4.3 Cange in IPSS score
Benign Prostate Hyperplasia · Erectile Dysfunction
Primary: Change From Baseline in Total International Prostate Symptom Score (IPSS) at Week 12 — -4.08; -5.49; -4.92 units on a scale
Benign Prostatic Hyperplasia
Primary: Number of Adverse Events Reported — 7 adverse events
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 12 Week Endpoint in International Prostate Symptom Score (IPSS) Total Score — 17.3; 17.1; 17.7; -4.2 units on a scale — p=0.073